Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary interventionEun Ho Choo, Ki‐Bae Seung, Kiyuk Chang et al.|Heart|2014Cited by 79
The impact of no-reflow phenomena after primary percutaneous coronary interventionEun Ho Choo, Ki‐Bae Seung, Ki‐Dong Yoo et al.|Coronary Artery Disease|2014Cited by 42
Thyroid stimulating hormone elevation as a predictor of long‐term mortality in patients with acute myocardial infarctionSuk Min Seo, Ki‐Bae Seung, Yoon‐Seok Koh et al.|Clinical Cardiology|2018Cited by 32
Clinical Significance of Chronic Kidney Disease and Atrial Fibrillation on Morbidity and Mortality in Patients with Acute Myocardial InfarctionHyeon Seok Hwang, Youngkeun Ahn, Mahn‐Won Park et al.|American Journal of Nephrology|2014Cited by 21
Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary interventionMahn‐Won Park, Kiyuk Chang, Sung‐Ho Her et al.|Pharmacogenetics and Genomics|2013Cited by 18